Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD  |  Issue: May 2023  |  May 9, 2023

Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV); however, it’s rarely reported as the initial presenting symptom.1,2

Here, we present a case of GPA with migratory polyarthritis as the initial manifestation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

History of present illness: A 49-year-old man without significant medical history presented to the rheumatology clinic for evaluation of polyarthritis that had started eight months before. He reported three episodes of migratory polyarthritis, involving different joints each time (i.e., shoulders; elbows and wrists; knees, and ankles). During each episode, he noted joint swelling, redness (see Figures 1A and 1B), stiffness and pain; his symptoms lasted for five days and then resolved after he received a course of glucocorticoids.

During the second flare, he experienced redness, pain and floaters in both eyes, which also improved with glucocorticoids. He was subsequently seen by an ophthalmologist, who diagnosed him with bilateral iritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, he described chronic low back pain that worsened with exercise and prolonged morning stiffness that he’d experienced for a few years.

FIGURE 1A. Click to enlarge.

Three weeks before his rheumatology visit, he visited the emergency department for evaluation during an inflammatory flare. Plain X-ray films of his ankles showed mild to moderate soft tissue swelling without evidence of acute fracture or osseous abnormalities.

Laboratory tests are summarized in Table 1.

He was discharged on a glucocorticoid regimen and was referred to a rheumatology clinic.

Past medical history & medications: The patient had no pertinent, previous medical history or surgery. The patient’s medications were 10 mg of prednisone daily and 800 mg of ibuprofen twice daily as needed. He denied any recent antibiotic or other medication use, herbal use or vaccination.

FIGURE 1B. Click to enlarge.

Social & family history: He reported no family history of psoriasis, rheumatoid arthritis (RA), inflammatory bowel disease (IBD) or other autoimmune conditions. He has been smoking one pack per day for 10 years. He consumes alcohol socially and denies using any recreational drugs, such as cocaine or heroin. He has lived in Ohio with the same female partner for many years, with no recent travel.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportGranulomatosisgranulomatosis with polyangiitismigratory polyarthritis

Related Articles

    ANCA-Associated Vasculitis Trial Results May Change Standard of Care

    May 15, 2020

    SNOWMASS VILLAGE, COLO.—The study of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is ongoing, and research results should help improve treatment for this patient pop­ulation. Key trials and therapeutic options were discussed at the 2020 ACR Winter Symposium during the session, Update on the Treatment of ANCA-Associated Vasculitis, by Peter A. Merkel, MD, MPH, chief of…

    Mortality from Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Falling Slightly

    October 9, 2019

    NEW YORK (Reuters Health)—Mortality rates in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) decreased from 1999 to 2017, according to records from the Centers for Disease Control and Prevention (CDC). “The mortality attributed to several rare diseases [e.g., hypersensitivity pneumonitis] has increased in recent years,” Alexander W. Steinberg, MD, from Saint Joseph Hospital, Denver, tells…

    Trimethoprim-Sulfamethoxazole Prophylaxis Reduced Rituximab Infection Risk

    October 18, 2018

    Severe infections occurred in 25% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) who were treated with rituximab, according to results of an observational study conducted in the United Kingdom (U.K.) and Austria. Trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis, however, reduced the risk of severe infections, the investigators reported in Annals of the Rheumatic Diseases.1 Andreas…

    ANCA Mortality: Are Patients Doing Better?

    December 13, 2019

    Patients with anti-neutrophil cytoplasmic antibody–associated vasculitides (AAV) have an increased risk of mortality. But treatments have evolved in recent years. Recent research found that between 1999 and 2017 the AAV mortality rate declined by nearly 2% per year in patients 65–74 years old…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences